Transdermal testosterone gel (DrugBank: Testosterone)
8 diseases告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
1 | 球脊髄性筋萎縮症 | 0 |
2 | 筋萎縮性側索硬化症 | 0 |
3 | 脊髄性筋萎縮症 | 0 |
13 | 多発性硬化症/視神経脊髄炎 | 0 |
60 | 再生不良性貧血 | 0 |
78 | 下垂体前葉機能低下症 | 1 |
113 | 筋ジストロフィー | 0 |
265 | 脂肪萎縮症 | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT00144391 (ClinicalTrials.gov) | July 2003 | 1/9/2005 | Testosterone Gel Applied to Women With Pituitary Gland Problems | Physiologic Testosterone Replacement in Women With Hypopituitarism | Panhypopituitarism | Drug: Transdermal Testosterone gel | Charles Drew University of Medicine and Science | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Completed | 18 Years | 55 Years | Female | 20 | Phase 4 | United States |